News about Market

Evernorth Invests USD 3.5 Billion in Shields to Deepen Specialty Pharmacy Reach

Evernorth Invests USD 3.5 Billion in Shields to Deepen Specialty Pharmacy Reach

Evernorth, a subsidiary of Cigna Group, is investing USD 3.5 billion in Shields Health Solutions, a company focused on specialty pharmacy management. This investment arrives as Shields establishes itself as a standalone entity following its acquisition by private equity firm Sycamore Partners after the Walgreens demerger.

Market | 03/09/2025 | By Darshana

CapVest Acquires Majority Stake in Stada, Abandoning IPO Plans

CapVest Acquires Majority Stake in Stada, Abandoning IPO Plans

CapVest Partners, a London-based private equity firm, has agreed to acquire a majority stake in German pharmaceutical company Stada Arzneimittel, effectively halting the drugmaker’s previously explored initial public offering (IPO).

Market | 02/09/2025 | By Darshana

Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata

Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata

Twenty biopharmaceutical companies have reported a 5.7 percent quarter-on-quarter (QoQ) downturn in their combined market capitalisation from USD 3.9 trillion on 31 March, 2025 to USD 3.7 trillion on 30 June, 2025.

Market | 01/09/2025 | By Dineshwori

Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve

Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve

Stada and its owners are also considering alternative ownership options, including a potential sale. The company previously held talks with private equity firm CapVest, which would have valued Stada at around 10 billion euro including debt. Those discussions have since stalled, prompting a stronger push toward the IPO route.

Market | 29/08/2025 | By Darshana

Global pharmaceutical stability and storage services market: APAC to Register Fastest Growth Over the Next Decade

Global pharmaceutical stability and storage services market: APAC to Register Fastest Growth Over the Next Decade

While North America is projected to remain the largest market for pharmaceutical stability and storage services, the Asia-Pacific (APAC) region is expected to record the fastest CAGR during the forecast period.

Market | 29/08/2025 | By Dineshwori

Santhera Partners with Ikris Pharma Network for Distribution of AGAMREE in India

Santhera Partners with Ikris Pharma Network for Distribution of AGAMREE in India

Swiss specialty pharma company Santhera Pharmaceuticals has entered into an exclusive agreement with Ikris Pharma Network to distribute AGAMREE (vamorolone) in India for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above.

Market | 29/08/2025 | By Dineshwori 110

Esaote North America and Epica International Partner to Expand MRI and CT Imaging Market Reach

Esaote North America and Epica International Partner to Expand MRI and CT Imaging Market Reach

Esaote North America has entered into a strategic partnership with Epica International to expand market presence and accelerate the adoption of high-performance MRI and CT solutions across the human and veterinary healthcare sectors.

Market | 28/08/2025 | By Dineshwori

Osstem Implant Strengthens Global Footprint with India as Key Growth Market

Osstem Implant Strengthens Global Footprint with India as Key Growth Market

Osstem Implant’s success in India – one of the fastest-growing dental implant markets – is driven by a dual focus on innovation and education.

Market | 28/08/2025 | By Dineshwori 208

Laborate's Aqualab Eyes INR 250 Crore with Retail-First Model by FY 25-26

Laborate's Aqualab Eyes INR 250 Crore with Retail-First Model by FY 25-26

Since its inception in 2022, Laborate’s direct-to-retail division, Aqualab, has reported consistent year-on-year growth, moving from INR 76 crore in FY 2022–23 to INR 108 crore in FY 2023–24.

Market | 27/08/2025 | By Dineshwori

US EoE Market Expected to Hit USD 1.19 Billion by 2030, Driven by Next-Gen Therapies

US EoE Market Expected to Hit USD 1.19 Billion by 2030, Driven by Next-Gen Therapies

The US market for eosinophilic esophagitis (EoE) is projected to soar from USD 202 million in 2020 to USD 1.19 billion by 2030, reflecting a compound annual growth rate (CAGR) of 19.4 percent, according to GlobalData. This substantial growth is being driven by a transition away from off-label treatments toward FDA-approved, patient-friendly therapies.

Market | 25/08/2025 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members